EPRX Eupraxia Pharmaceuticals Inc.
Company Analysis
Latest News
🔴 Eupraxia Pharmaceuticals is trading 6.3% down
Eupraxia Pharmaceuticals is trading at $8.53, down 6.32%; reporting identifies no new company-specific catalyst. - On September 30, shares rose 9.57% to $9.10...
Eupraxia's One-Shot EoE Drug Holds Patients in Remission for a Year — But Can a 14-Patient Trial Justify a $600 Million Bet?
Shares of Eupraxia Pharmaceuticals surged 10.6% to $9.19 after the clinical-stage biotech reported that a single dose of its swallowed steroid capsule kept 64%...
🟢 Eupraxia Pharmaceuticals is trading 10.63% up today after 64% remained in remission at 52 weeks
Eupraxia Pharmaceuticals is trading 10.63% up at $9.19; the clearest catalyst is its September 30 RESOLVE trial report. - In Phase 1b/2a, 9 of 14 patients...
🟢 Eupraxia Pharmaceuticals is trading 5.48% up today amid 52-week clinical remission results
Eupraxia Pharmaceuticals is trading 5.48% higher at $8.76, amid company-reported Phase 1b/2a RESOLVE trial results. - On September 30, 2026, 64% (9 of 14)...
🟢 Eupraxia Pharmaceuticals is trading 6% up in pre-market
Eupraxia Pharmaceuticals is trading at $8.49, up 5.99% in pre-market; no company-specific announcement explaining the September 28 gain was identified. - The...
Two Wall Street Firms Bet Big on Eupraxia's Throat Treatment — But Can a $9 Stock Really Be Worth $25?
Shares of Eupraxia Pharmaceuticals surged 10.6% to $9.00 on September 24 after two analyst upgrades converged on the same thesis: the company's experimental...
🟢 Eupraxia Pharmaceuticals is trading 11% up in pre-market after Stifel reiterated Buy ahead of interim data
Eupraxia Pharmaceuticals is trading 10.57% higher at $9.00 after Stifel reiterated a Buy rating and $25.00 price target on September 24, 2026, ahead of interim...
🔴 Eupraxia Pharmaceuticals is trading 5.94% down today amid a 1.04% Nasdaq Composite decline
Eupraxia Pharmaceuticals is trading 5.94% lower at $8.07, with the decline appearing mainly aligned with weaker broader-market sentiment during the September...
🟢 Eupraxia Pharmaceuticals is trading 5% up in after-hours trading; catalyst unconfirmed
Eupraxia Pharmaceuticals is trading 5.07% up at $8.50 after closing at $8.09 on September 16, 2026; the catalyst remains unconfirmed. - Recent...
🟢 Eupraxia Pharmaceuticals is trading 5.49% up today after August CPI data
Eupraxia Pharmaceuticals is trading 5.49% up at $8.46 as major U.S. indexes rise more than 1% following August CPI data, supporting broader risk appetite...
🟢 Eupraxia Pharmaceuticals is trading 6.42% up in pre-market after Nasdaq Global Select Market trading began
Eupraxia Pharmaceuticals is trading 6.42% up now at $8.78 after announcing on September 8, 2026, that its shares began trading on the Nasdaq Global Select...
🟢 Eupraxia Pharmaceuticals is trading 10.53% up today with no confirmed catalyst identified
Eupraxia Pharmaceuticals is trading at $8.29, up +10.53% on September 4, 2026, with no confirmed company-specific catalyst identified. - The Nasdaq Global...
🟢 Eupraxia Pharmaceuticals is trading 6.67% up today with no clear catalyst identified
Eupraxia Pharmaceuticals is trading 6.67% up at $8.00 on September 4, 2026; no new company-specific announcement or reliable source explicitly explains the...
🟢 Eupraxia Pharmaceuticals is trading 6.67% up in after-hours trading amid broader healthcare-sector strength
Eupraxia Pharmaceuticals is trading at $8.00, up 6.67%, amid broader healthcare strength and a risk-on market; company-specific causation remains...
🟢 Eupraxia Pharmaceuticals is trading 7.38% up today in after-hours trading amid broader healthcare-sector strength
Eupraxia Pharmaceuticals is trading 7.38% up now at $8.00 in after-hours trading, supported by broader healthcare-sector strength and a generally positive...
🟢 Eupraxia Pharmaceuticals is trading 12% up today as healthcare gains 1.37%
Eupraxia Pharmaceuticals is trading 11.83% up now at $7.09, with broader healthcare strength appearing to drive the move. - No clear company-specific...
🟢 Eupraxia Pharmaceuticals is trading 8% up today as Healthcare gains 1.37%
Eupraxia Pharmaceuticals is trading 8.04% up at $6.85, with the move appearing supported by broader healthcare-sector strength; no clear company-specific...
🔴 Eupraxia Pharmaceuticals is trading 5% down in pre-market with no clear company-specific catalyst
Eupraxia Pharmaceuticals is trading 5.21% down now at $6.01 after no clear company-specific catalyst was identified for September 2, 2026. - Its latest...
🟢 Eupraxia Pharmaceuticals is trading 13.78% up today in pre-market with no clear company-specific catalyst identified
Eupraxia Pharmaceuticals is trading 13.78% up at $7.35 after no clear company-specific catalyst was identified for September 1, 2026. • No September 1...
🔴 Eupraxia Pharmaceuticals is trading 5% down today
Eupraxia Pharmaceuticals is trading 5.02% down at $6.34, with no clear company-specific catalyst dated August 31 identified. - The decline extends the move...